Survival on dialysis varies widely. About 25% of people die within the first year, and five‑year survival can range from roughly 35% to 85% depending on age and overall health. Younger, fitter people often live many years on dialysis; older or frail patients—especially those with heart disease or diabetes—tend to have a shorter life expectancy. Peritoneal dialysis may offer early benefits for some patients, but long‑term results are driven more by other health problems than by dialysis type. A kidney transplant typically improves lifespan. Below are details and the factors clinicians use to personalize expectations.
Key Takeaways
One‑year mortality on dialysis is about 25%; five‑year mortality is roughly 35–40% overall.
Younger patients do substantially better: five‑year survival is ≈85% for people under 45 and ≈60% for those aged 45–64.
Reported average survival differs by modality (hemodialysis ~8.8 years, peritoneal dialysis ~19.9 years) but those figures reflect selection bias.
Age, frailty, major comorbidities (especially heart disease and diabetes), and low albumin are strong predictors of shorter survival.
Kidney transplant—especially from a living donor—usually offers longer survival than remaining on dialysis; conservative (no‑dialysis) care prioritizes quality of life.
What the Data Say About Survival on Dialysis
How long someone lives on dialysis depends mainly on age, overall health, and treatment choice. Population studies show wide variation: one‑year mortality is about 25%, and five‑year survival is roughly 35–40% on average, with big differences by age group. People under 45 can have five‑year survival near 85%; ages 45–64 around 60%; rates fall further in older groups. Reported life expectancy also varies by modality—some series show mean survival near 8.8 years for hemodialysis versus about 19.9 years for peritoneal dialysis—but selection bias affects those numbers. Prognostic factors such as functional status, frailty, serum albumin, and other illnesses strongly shape outcomes and help clinicians set individualized expectations.
How Age and Overall Health Change Prognosis
Age strongly affects outcomes because it correlates with physiologic reserve and the overall burden of comorbidity. Five‑year survival is roughly 85% for people under 45, about 60% for ages 45–64, and declines after 64, with many aged 80+ having substantially shorter life expectancy. Clinicians combine age with measures of functional status, frailty, and comorbidity scores to offer a realistic outlook. Markers of nutrition and inflammation—like serum albumin—also predict mortality and can change survival estimates beyond chronological age. Using these combined tools helps patients and clinicians weigh likely outcomes and treatment trade‑offs.
Differences Between Hemodialysis and Peritoneal Dialysis
The practical and medical differences between hemodialysis and peritoneal dialysis go beyond where treatment happens. Hemodialysis uses a machine and vascular access and is most often done in a center three times a week; peritoneal dialysis uses the peritoneal membrane at home with daily exchanges or automated overnight cycles. These differences affect infection risks, complication patterns, scheduling, and independence. Some studies report early survival advantages or longer average survival with peritoneal dialysis for selected patients, but long‑term outcomes are more closely tied to age, comorbidities, and functional status than to modality alone. Choosing a modality should match the medical picture, lifestyle, and patient preference.
Factors That Improve or Shorten Life Expectancy
Which factors most affect survival on dialysis? Age is a primary driver: five‑year survival drops with increasing age. Frailty and a high burden of other illnesses—especially diabetes and heart disease—predict shorter survival, while well‑managed conditions improve outlook. Low albumin, a sign of poor nutrition or inflammation, is linked to higher mortality. Dialysis modality can influence early patterns, with some populations showing short‑term advantages for peritoneal dialysis; long‑term differences vary. Timing of dialysis initiation has trade‑offs: starting earlier may extend life modestly but can increase hospital time. Overall, individual functional status and medical complexity determine outcomes, so a personalized assessment is essential for realistic planning.
When Transplantation or Conservative Care Alters the Outlook
Choosing transplant or conservative (no‑dialysis) care changes the prognosis substantially. Transplantation generally leads to better outcomes than staying on dialysis: a healthy 65‑year‑old may live ~12 years after transplant versus ~3.6 years on dialysis. Live‑donor transplants typically provide longer survival and fewer complications than deceased‑donor transplants and reduce time spent waiting. Conservative care focuses on symptom control and quality of life; for some older or very frail patients it may be the most appropriate choice even if it shortens life compared with dialysis. Prognostic tools—age‑adjusted Charlson scores, albumin, functional status, and frailty measures—help guide discussions about likely survival, recovery, and trade‑offs for each treatment path.
Frequently Asked Questions
What Is the Life Expectancy of a Person on Dialysis by Age?
Estimates vary by age: under 45 often about 15–30 years; ages 45–64 roughly 8–20 years; 65–79 commonly 5–15 years; and 80+ often months to a few years, depending on overall health and frailty.
How Does Being on Dialysis Affect Your Life?
Dialysis changes daily life. It brings scheduled treatments, diet and fluid limits, fatigue, and risks such as infection or access problems. It can affect work, travel, and social plans and requires ongoing medical follow‑up and emotional adjustment. Many people adapt and keep active, but life often needs practical planning and support.
Is It Painful to Be on Dialysis?
Dialysis itself isn’t usually painful, but some people feel cramps, nausea, dizziness, or soreness during or after sessions. Discomfort varies by treatment type and individual. Clinicians can adjust settings, medicines, and techniques to reduce symptoms and improve comfort.
How Long Can a Kidney Failure Live?
Life expectancy with kidney failure ranges from months to decades and commonly falls between about 8–20 years on dialysis, though individual outcomes depend heavily on age, frailty, albumin levels, other health conditions, and the chosen treatment approach.
Frequently Asked Questions
What Is the Life Expectancy of a Person on Dialysis by Age?
Estimates vary by age: under 45 often about 15–30 years; ages 45–64 roughly 8–20 years; 65–79 commonly 5–15 years; and 80+ often months to a few years, depending on overall health and frailty.
How Does Being on Dialysis Affect Your Life?
Dialysis changes daily life. It brings scheduled treatments, diet and fluid limits, fatigue, and risks such as infection or access problems. It can affect work, travel, and social plans and requires ongoing medical follow‑up and emotional adjustment. Many people adapt and keep active, but life often needs practical planning and support.
Is It Painful to Be on Dialysis?
Dialysis itself isn’t usually painful, but some people feel cramps, nausea, dizziness, or soreness during or after sessions. Discomfort varies by treatment type and individual. Clinicians can adjust settings, medicines, and techniques to reduce symptoms and improve comfort.
How Long Can a Kidney Failure Live?
Life expectancy with kidney failure ranges from months to decades and commonly falls between about 8–20 years on dialysis, though individual outcomes depend heavily on age, frailty, albumin levels, other health conditions, and the chosen treatment approach.
Count on https://drugmart.com When You Need to Import Prescription Drugs Through Canada When you work with https://drugmart.com, ordering medicine through Canada is easy, safe and cost-effective. You can rely on our reputable network of pharmacies to deliver the authentic drugs you need. If you're ready to import prescription drugs through Canada and our other verified international pharmacies, you can start today by browsing our available medications.
Sources
Kim, S. (2025). Clinical challenges and individualized approaches to dialysis therapy in older adults. The Korean Journal of Internal Medicine, 40(6), 909-926. https://kjim.org/journal/view.php?doi=10.3904/kjim.2025.147
Hunter‐Dickson, M., Huang, A., Drak, D., Zheng, C., & Gracey, D. (2025). Outcomes of Dialysis Patients Living With HIV in Australia and New Zealand: A Cohort Study Using the Australia and New Zealand Dialysis and Transplant Registry ( ANZDATA ). Nephrology, 30(9). https://onlinelibrary.wiley.com/doi/10.1111/nep.70115
Auguste, B. and Chan, C. (2019). Home Dialysis Among Elderly Patients: Outcomes and Future Directions. Canadian Journal of Kidney Health and Disease, 6. https://journals.sagepub.com/doi/10.1177/2054358119871031
Kurazumi, H., Takahashi, M., & Ikenaga, S. (2019). Outcomes of cardiovascular surgery for chronic dialysis patients in current Japan. Asian Cardiovascular and Thoracic Annals, 27(6), 464-470. https://journals.sagepub.com/doi/10.1177/0218492319859147
Related Articles
Your Go-To for Affordable Prescriptions
Looking for ways to save on your medications? Discount pharmacies are a smart choice for getting budget-friendly prescriptions. They often feature impressive price cuts, making essential healthcare more within...
Importing Prescription Drugs for Personal Use: Is the Importation of Drugs from Canada Safe?
Talk about the importation of drugs is frequently in the news. But what does that mean for Americans? Is importing prescription drugs for personal use legal?...
Methocarbamol: common side effects and when to get help
Methocarbamol commonly causes drowsiness, dizziness, nausea, blurred vision, and headache, usually soon after treatment begins. Less common reactions include fainting, ongoing vomiting,...
